Eagle Pharmaceuticals (EGRX) Earnings
|
Expand Research on EGRX
| Next EPS Date | 5/7/24 | EPS Growth Rate | -22.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +2.4% | Revenue Growth Rate | -13.0% |
| Average % Move 1-Wk after EPS | -9.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/24 | Q124 | N/A | $0.98 | N/A | N/A | $57.7M | N/A | N/A | N/A | ||
| 2/28/24 | Q423 | N/A | $1.07 | N/A | N/A | $64.5M | = | N/A | N/A | ||
| 3/11/24 | Q423 | N/A | $1.07 | N/A | N/A | $64.5M | = | N/A | N/A | ||
| 3/25/24 | Q423 | N/A | $1.07 | N/A | N/A | $64.5M | = | N/A | N/A | ||
| 3/18/24 | Q423 | N/A | $1.07 | N/A | N/A | $64.5M | = | N/A | N/A | ||
| 11/6/23 | Q323 | N/A | $1.06 | N/A | N/A | $62.6M | = | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | $1.06 | N/A | N/A | $62.6M | = | N/A | N/A | ||
12/29/23  |
Q323 | N/A | $1.09 | N/A | N/A | $62.8M | = | N/A | N/A |
